Delta hepatitis: an update (Q34288172)

1 August 2017

1 reference

title

Delta hepatitis: an update (English)

1 reference

1 August 2017

Patrizia Farci

1

1 reference

1 August 2017

1 January 2003

1 reference

1 August 2017

Journal of Hepatology

1 reference

1 August 2017

39 Suppl 1

1 reference

1 August 2017

S212-9

1 reference

Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Transmission of the hepatitis B virus-associated delta antigen to chimpanzees

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Structure, sequence and expression of the hepatitis delta (delta) viral genome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

The hepatitis delta (delta) virus possesses a circular RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

The size of the hepatitis delta agent

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Antigenomic RNA of human hepatitis delta virus can undergo self-cleavage.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Self-ligating RNA sequences on the antigenome of human hepatitis delta virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Imidazole rescue of a cytosine mutation in a self-cleaving ribozyme

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

General acid-base catalysis in the mechanism of a hepatitis delta virus ribozyme

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

A Replication Cycle for Viroids and Other Small Infectious RNA's

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

The RNAs of hepatitis delta virus are copied by RNA polymerase II in nuclear homogenates.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Stimulation of RNA polymerase II elongation by hepatitis delta antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

The molecular biology of hepatitis delta virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

A single antigenomic open reading frame of the hepatitis delta virus encodes the epitope(s) of both hepatitis delta antigen polypeptides p24 delta and p27 delta

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

RNA editing of hepatitis delta virus antigenome by dsRNA-adenosine deaminase

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Rapid evolution of RNA genomes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Selforganization of matter and the evolution of biological macromolecules

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Evolution of hepatitis delta virus RNA during chronic infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Sequence conservation and divergence of hepatitis delta virus RNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

A genotype of hepatitis D virus that occurs in northern South America

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Hepatitis delta virus genotypes I and II cocirculate in an endemic area of Yakutia, Russia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Hepatitis B virus (HBV)/hepatitis D virus (HDV) coinfection in outbreaks of acute hepatitis in the Peruvian Amazon basin: the roles of HDV genotype III and HBV genotype F.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Characterization of hepatitis D virus genotype III among Yucpa Indians in Venezuela

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Transmission of the hepatitis B virus-associated delta agent to the eastern woodchuck.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Experimental transmission of human hepatitis delta virus to the laboratory mouse

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Replication of the human hepatitis delta virus genome Is initiated in mouse hepatocytes following intravenous injection of naked DNA or RNA sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Sustained survival of human hepatocytes in mice: A model for in vivo infection with human hepatitis B and hepatitis delta viruses.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Hepatitis D virus and human immunodeficiency virus antibodies in parenteral drug abusers who are hepatitis B surface antigen positive

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Risk of post-transfusion infection with the hepatitis delta virus. A multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Familiar clustering and spreading of hepatitis delta virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Heterosexual transmission of hepatitis delta virus in the general population of an area endemic for hepatitis B virus infection: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Intrafamilial transmission of hepatitis delta virus: molecular evidence.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Incidence and risk factors of acute Delta hepatitis in Italy: results from a national surveillance system. SEIEVA Collaborating Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Decrease in HDV endemicity in Italy.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Chronic hepatitis D: a vanishing Disease? An Italian multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Infection with delta agent in Sweden: introduction of a new hepatitis agent

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Seroepidemiological study of hepatitis delta virus infection in Okinawa, Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

A study of hepatitis delta virus infection in patients with acute and chronic liver disease from northern India

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

An outbreak of fulminant hepatitis delta in the Waorani, an indigenous people of the Amazon basin of Ecuador

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Serologic markers with fulminant hepatitis in persons positive for hepatitis B surface antigen. A worldwide epidemiologic and clinical survey

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Clearance of hepatitis B surface antigen in chronic carriers of hepatitis delta antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Patterns of hepatitis delta virus reinfection and disease in liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Direct evidence for cytotoxicity associated with expression of hepatitis delta virus antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

A histological study of hepatitis delta virus liver disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Deleterious effects of hepatitis delta virus replication on host cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Human CD4+ T-cell response to hepatitis delta virus: identification of multiple epitopes and characterization of T-helper cytokine profiles.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Recognition of uridine diphosphate glucuronosyl transferases by LKM-3 antibodies in chronic hepatitis D.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

The predominance of hepatitis delta virus genotype I among chronically infected Italian patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Rapidly progressive HBsAg-positive hepatitis in Italy. The role of hepatitis delta virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Changing pattern of chronic hepatitis D in Southern Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. The European Concerted Action on Viral Hepatitis (Eurohep)

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Infection with the delta agent in children

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

A retrospective study of the role of delta agent infection in children with HBsAg-positive chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Long-term evolution of chronic delta hepatitis in children

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Liver disease activity and hepatitis B virus replication in chronic delta antigen-positive hepatitis B virus carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

δ Infection in asymptomatic carriers of hepatitis B surface antigen: Low prevalence of δ activity and effective suppression of hepatitis B virus replication

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Natural history of hepatitis D viral superinfection: significance of viremia detected by polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Hepatitis B virus replication modulates pathogenesis of hepatitis D virus in chronic hepatitis D.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Suppression of hepatitis C virus (HCV) replication by hepatitis D virus (HDV) in HIV-infected hemophiliacs with chronic hepatitis B and C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Replication status and histological features of patients with triple (B, C, D) and dual (B, C) hepatic infections

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Lack of HBV and HDV replicative activity in HBsAg-positive intravenous drug addicts with immune deficiency due to HIV

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Influence of human immunodeficiency virus infection on hepatitis delta virus superinfection in chronic HBsAg carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Chronic delta hepatitis: is the prognosis worse when associated with hepatitis C virus and human immunodeficiency virus infections?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Persistent delta antigenaemia in chronic delta hepatitis and its relation with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Immunohistochemical differentiation of hepatitis D virus genotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Diagnostic and prognostic significance of the IgM antibody to the hepatitis delta virus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Serum immunoglobulin M antibody to hepatitis D as a surrogate marker of hepatitis D in interferon-treated patients and in patients who underwent liver transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Ribavirin treatment for chronic hepatitis D: a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Famciclovir treatment of chronic delta hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Lamivudine for chronic delta hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Lamivudine-high dose interferon combination therapy for chronic hepatitis B patients co-infected with the hepatitis D virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Treatment of chronic hepatitis D with interferon alfa-2a

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Loss of HBsAg with interferon-alpha therapy in chronic hepatitis D virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Elimination of hepatitis delta virus infection after loss of hepatitis B surface antigen in patients with chronic delta hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Use of α-interferon in the treatment of chronic delta hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

The French experience of treatment of chronic type D hepatitis with a 12-month course of interferon alpha-2B. Results of a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Resolution of chronic delta hepatitis after 12 years of interferon alfa therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

Immunization of woodchucks (Marmota monax) with hepatitis delta virus DNA vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

DNA-Based immunization produces Th1 immune responses to hepatitis delta virus in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900331-3

7 January 2021

10.1016/S0168-8278(03)00331-3

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

14708706